Financials

News Ideas Technicals Forecast

ADAP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Adaptimmune Therapeutics plc

Total assets of ADAP for Q4 23 is 282.62 M USD, 4.73% less than the previous Q3 23. And total liabilities increased by 16.59% in Q4 23 to 243.1 M USD.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—